About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
Mutant Prevention Concentration Of SMT19969 Against Clinical Isolates Of Clostridium Difficile Mutant Prevention Concentration Of SMT19969 Against Clinical Isolates Of Clostridium Difficile October 13, 2014 By CKD Digital
Mutant Prevention Concentration Of SMT19969 Against Clinical Isolates Of Clostridium Difficile October 13, 2014 By CKD Digital
